Andrew Tindall - Apr 14, 2022
Horizons in vaccine production
The scramble for a coronavirus vaccine over the last two years has demonstrated how important vaccines are to containing infectious disease. The coronavirus vaccine has broken the link between infections and hospitalisations, and this remains a vital part of the strategy for combatting Covid-19 and...
A much-needed boost: the future of coronavirus vaccines
Just over two years after our first blog on Covid-19, it appears that..
Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic
There is no denying that the Covid-19 pandemic has reshaped many..
Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection
Human health is inextricably linked to food – not least because..
A sense of hope with graphene-based COVID-19 detection
With mass COVID-19 vaccinations being rolled out by countries across..
COVID-19 win for AI pharma farmers
The vaccine roll-out is in action all over the world. Nevertheless,..
EPO 2020 Patent Index - key trends
The European Patent Office (EPO) recently published its 2020 Patent..
SARS-CoV-2 variants – reasons to be optimistic
In recent weeks and months, several highly-transmissible variants of..
Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself?
Respiratory viruses such as coronaviruses are notorious for evading..
AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2
AstraZeneca/Oxford University have announced that their SARS-CoV-2..
Protective barriers against COVID-19 – what’s behind the screen?
Since the outbreak of the COVID-19 pandemic there has been a..
And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy
Moderna have announced that their SARS-CoV-2 vaccine candidate..
Pfizer and BioNTech vaccine provides protection against SARS-CoV-2
Pfizer/BioNTech have now released more data from the Phase 3 clinical..
COVID-19 rescue act or major overhaul of the UK insolvency framework?
As we go into England’s second national lockdown of this COVID-19..
Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115
Our client, Hummingbird Bioscience, has received..
Facing facts: How the rise of face coverings has brought IP risks
Forward: features discuss and celebrate the best of innovation and..
Combatting COVID-19: does Vitamin D have a role to play?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), better..
Team Home or Team Office: the challenges of a COVID-19 secure workplace
Solicitor Hilda-Georgina Kwafo-Akoto discusses how the COVID-19..
“Test, test, test” – the importance of diagnostics in pandemic preparedness
While the world waits for a vaccine to be developed and approved for..
Industry makeover: how the cosmetics industry has been affected by COVID-19
The cosmetics industry has undergone a major transformation during..
Cellular immunity – a contributor to COVID-19 “dark matter”?
Immunologist Karl Friston of University College London has theorized..
Can CRISPR help us in the fight against COVID-19?
As countries across the world continue to face widespread disruption..
Links between COVID-19 severity and the immune system
The mechanism through which SARS-CoV-2, the virus that causes..
Branding in times of crisis: It’s time to make your mark meaningful
David Benady explains why a brand based on solid values is now a..
Is faster drug development likely to become the “new normal?”
As part of our Thought Leaders series, Mewburn Ellis Partner Sarah..
COVID-19: Suspension of Surcharge for Late Payment of Renewal Fees at the EPO
The European Patent Office (EPO) now has a dedicated webpage..
Contact tracing – our route out of the coronavirus (COVID-19) lockdown?
It appears that the United Kingdom is now past the peak of the..
Electronic signatures, “the new normal”?
The COVID-19 pandemic and resulting social distancing has meant that..
Fashion and the coronavirus (COVID-19) pandemic: brand protection should never go out of style
The fashion industry like all other industries is navigating..
New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies
Our client, Duke-NUS, has helped to develop a new, rapid serological..
From airbags to medical gowns – Autoliv continues to save lives to help fight against coronavirus (COVID-19)
Companies around the world are pivoting to help meet global shortages..
Counterfeit contagion: fraudulent activities spread amid coronavirus (COVID-19)
The COVID-19 outbreak has caused disruption to manufacturing..
How computer modelling has been used during the coronavirus (COVID-19) outbreak to inform political decisions
Throughout the emergence and continued spread of the novel..
Coronavirus (COVID-19) extension at the EPO: Part 2
The European Patent Office (EPO) now has a dedicated webpage..
BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19)
In the fight against the coronavirus pandemic, bemcentinib produced..
The power of trade marks: social distancing logos during the coronavirus (COVID-19) pandemic
We are all now familiar with the social distancing guidelines set out..
Graphene masks: facing up to coronavirus (COVID-19)
Since the development and isolation of graphene by researchers at..
Temporary modification of production conditions for PGIs and PDOs will help farmers struggling to deal with coronavirus (COVID-19)
The coronavirus lockdowns across many European countries have brought..
Governments look to protect companies from IP enforcement during the coronavirus (COVID-19) pandemic
A large effort is underway globally to ensure that there are enough..
Coronavirus (COVID-19), big data and silver linings
There is no denying that the COVID-19 pandemic will have tremendous..
How 3D printing is helping in the fight against coronavirus (COVID-19)
In a crisis which has been defined by its pace of change, 3D printing..
Has a cure for coronavirus (COVID-19) already been made?
Faced with the biggest global pandemic in most of our lifetimes, all..
Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak
In recent weeks there’s been a lot of discussion in the media of..
Crown Use during the coronavirus (COVID-19) pandemic
As discussed in a previous blog, the UK Government has the power to..
Why a "COVID-19” trade mark should be rejected
The COVID-19 pandemic has undoubtedly forced us all to adapt our..
What use is computational biology during the coronavirus (COVID-19) pandemic?
There is one obvious way in which computational biology is showing..
3D printing community responds to the coronavirus (COVID-19) challenge
The coronavirus (COVID19) pandemic has left healthcare systems..
Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective
Recent interesting reports highlight an emerging practice borne out..
A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)
Our Singapore based-clients A*STAR (Agency for Science, Technology..
Coronavirus (COVID-19): a case study in emerging disease
UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production,..
Changes to our correspondence address
In response to the current situation in London due to Coronavirus..
Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended!
Part 2 of this blog was published on 17 April 2020. Please read for..
Coronavirus (COVID-19) Update
Updated: 2pm Sunday 1st November 2020
Mewburn Ellis took the..